BEND3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.765200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.649200E-01
Normal-vs-Stage2
8.411600E-01
Normal-vs-Stage3
2.209000E-01
Normal-vs-Stage4
9.776800E-01
Stage1-vs-Stage2
7.550800E-01
Stage1-vs-Stage3
1.827420E-01
Stage1-vs-Stage4
9.430000E-01
Stage2-vs-Stage3
2.868400E-01
Stage2-vs-Stage4
8.324200E-01
Stage3-vs-Stage4
2.642600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.605000E-01
Normal-vs-AfricanAmerican
3.531800E-01
Normal-vs-Asian
7.495800E-01
Caucasian-vs-AfricanAmerican
6.841600E-01
Caucasian-vs-Asian
2.598200E-01
AfricanAmerican-vs-Asian
1.724570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.488400E-01
Normal-vs-Female
8.970800E-01
Male-vs-Female
4.912200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.750600E-01
Normal-vs-Age(41-60Yrs)
7.507400E-01
Normal-vs-Age(61-80Yrs)
8.801400E-01
Normal-vs-Age(81-100Yrs)
7.897800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.737800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.367200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.082600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.282600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.336400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.010000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.428400E-01
Normal-vs-Daily Drinker
6.202200E-01
Normal-vs-Weekly Drinker
7.184000E-01
Normal-vs-Occasional Drinker
6.727000E-01
Normal-vs-Social Drinker
7.418200E-01
Non Drinker-vs-Daily Drinker
2.653200E-01
Non Drinker-vs-Weekly Drinker
9.170200E-01
Non Drinker-vs-Occasional Drinker
7.783600E-01
Non Drinker-vs-Social Drinker
7.866600E-01
Daily Drinker-vs-Weekly Drinker
1.393760E-01
Daily Drinker-vs-Occasional Drinker
9.094500E-02
Daily Drinker-vs-Social Drinker
1.451840E-01
Weekly Drinker-vs-Occasional Drinker
8.207000E-01
Weekly Drinker-vs-Social Drinker
8.312800E-01
Occasional Drinker-vs-Social Drinker
9.966400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.140800E-01
Normal-vs-Grade 2
6.860600E-01
Normal-vs-Grade 3
5.380600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.300800E-01
Grade 1-vs-Grade 3
7.627000E-01
Grade 1-vs-Grade 4
5.140800E-01
Grade 2-vs-Grade 3
6.792200E-01
Grade 2-vs-Grade 4
6.860600E-01
Grade 3-vs-Grade 4
5.380600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.923400E-01
Normal-vs-NonDiabetic
9.092200E-01
Diabetic-vs-NonDiabetic
8.541600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.128200E-01
Normal-vs-NoPancreatitis
9.607200E-01
Pancreatitis-vs-NoPancreatitis
9.460600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.944400E-01
Normal-vs-N1
9.082600E-01
N0-vs-N1
4.405600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.081000E-01
Normal-vs-TP53-NonMutant
6.353000E-01
TP53-Mutant-vs-TP53-NonMutant
5.239000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
